In focus · trending topic

USF Health Byrd Institute

2 stories · following the connections

USF Researcher Develops Therapeutic Vaccine to Combat Alzheimer’s Disease and Neurodegenerative Disorders

By Nasdaq OMXJan 30, 2017, 11:00 AM UTC

Alzamend Neuro Launches Regulation A+ Tier II SEC Qualified Offering

By Nasdaq OMXJan 3, 2017, 7:05 PM UTC